Corbus PharmaceuticalsCRBP
那斯達克 · USD
11.28
+0.37
(+3.39%)
收盤 09/02 03:59 (UTC+8)
09/02 03:59 (UTC+8)
Corbus PharmaceuticalsCRBP
11.28
+0.37
(+3.39%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | 36,190 | 24,304 | 21,966 | 24,417 | 19,152 | - | - | - | - | - |
研發費用 | 31,175 | 19,819 | 18,406 | 20,860 | 15,187 | 15,642 | 8,787 | 10,808 | 6,865 | 5,761 |
推銷及管理費用 | 5,015 | 4,485 | 3,560 | 3,557 | 3,965 | 4,133 | 3,818 | 4,697 | 4,123 | 3,861 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -36,190 | -24,304 | -21,966 | -24,417 | -19,152 | -19,775 | -12,605 | -15,505 | -10,988 | -9,623 |
其他收入及費用 | 1,153 | 1,335 | 1,411 | 1,075 | 1,490 | 2,797 | 3,075 | 2,103 | 1,643 | 2,901 |
利息費用 | - | - | - | - | - | - | - | 381 | 652 | - |
稅前純益 | -35,037 | -22,969 | -20,555 | -23,342 | -17,662 | -16,978 | -9,530 | -13,783 | -9,997 | -6,899 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -35,037 | -22,969 | -20,555 | -23,342 | -17,662 | -16,978 | -9,530 | -13,783 | -9,997 | -6,899 |
基本每股稅後盈餘(元) | -1.81 | -1.23 | -1.25 | -1.90 | -1.44 | -1.39 | -0.78 | -1.15 | -0.90 | -0.83 |
稀釋每股稅後盈餘(元) | -1.81 | -1.23 | -1.17 | -1.90 | -1.44 | -1.39 | -0.76 | -1.17 | -0.92 | -0.83 |
基本平均股數(千股) | 19407.00 | 18706.00 | 16482.00 | 12307.00 | 12240.00 | 12202.00 | 12179.00 | 12014.00 | 11053.00 | 8310.00 |
稀釋平均股數(千股) | 19407.00 | 18706.00 | 16482.00 | 12307.00 | 12240.00 | 12202.00 | 12179.00 | 12014.00 | 11053.00 | 8310.00 |
還原基本每股稅後盈餘(元) | -1.81 | -1.23 | -1.25 | -1.90 | -1.44 | -1.39 | -0.78 | -1.15 | -0.90 | -0.83 |
還原稀釋每股稅後盈餘(元) | -1.81 | -1.23 | -1.17 | -1.90 | -1.44 | -1.39 | -0.76 | -1.17 | -0.92 | -0.83 |
還原基本平均股數(千股) | 19,407 | 18,706 | 16,482 | 12,307 | 12,240 | 12,202 | 12,179 | 12,014 | 11,053 | 8,310 |
還原稀釋平均股數(千股) | 19,407 | 18,706 | 16,482 | 12,307 | 12,240 | 12,202 | 12,179 | 12,014 | 11,053 | 8,310 |
EBITDA(千元) | -35,212 | -23,266 | -21,198 | -23,342 | -18,029 | -17,101 | -10,223 | -13,807 | -10,021 | -7,469 |